Silver Book Fact

The number of Medicare beneficiaries newly diagnosed with wet age-related macular degeneratino (AMD) more than doubled between 1994 and 2006.

Day S, Acquah K, Lee P, Mruthyunjaya P, et al. Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007. Ophthalmol. 2011; 152(6): 1014-20. http://www.ajo.com/article/S0002-9394%2811%2900410-7/abstract

Reference

Title
Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007
Publication
Ophthalmol
Publication Date
2011
Authors
Day S, Acquah K, Lee P, Mruthyunjaya P, et al.
Volume & Issue
Volume 152, Issue 6
Pages
1014-20
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • The number of people in the U.S. with visual impairment or blindness is expected to double to more than 8 million by 2050.
     
  • Annual Total Burden to the U.S. Economy of AMD, Cararact, Diabetic Retinopathy, Glaucoma, Refractive Errors, Visual Impairment and Blindness  
  • In one study of patients age 48 and older, 17% of the women and 11.1% of the men had dry eye.  
  • An estimated 2,907,691 Americans age 40 and older have vision impairment.  
  • A study of Medicare beneficiaries with glaucoma showed that health care costs increased with degree of vision loss–ranging from $8,157 per year for no vision loss to $18,670 for blindness.